内镜颅底外科发展过程中的经验教训
本文比较内镜颅底外科(ESBS)与开颅手术(TCS)在2012年前和2012—2017年两个时段治疗颅咽管瘤、前颅底脑膜瘤、嗅神经母细胞瘤、脊索瘤和软骨肉瘤的手术结果,总结ESBS的演变与经验教训。
要点
- 对多数颅咽管瘤和脊索瘤,ESBS较TCS具有明显优势。
- 对经选择的蝶骨平台和鞍结节脑膜瘤,ESBS与TCS切除率相似,视力改善率更高。
- 对嗅沟脑膜瘤,TCS切除率更高且并发症更少。
核心结论
- ESBS正发展为一种成熟的术式,由经验丰富的外科医生用于合适病变时明确符合患者最佳利益。
- 持续对结果进行严格再评估对确保最佳疗效至关重要。
研究设计与样本
- 作者比较了ESBS与TCS在2012年前和2012—2017年两个不同时间段内治疗多种病变的手术结果,以观察结果随时间的变化。
- 所检查的病变为颅咽管瘤、前颅底脑膜瘤、嗅神经母细胞瘤、脊索瘤和软骨肉瘤。
主要发现
- 对多数颅咽管瘤和脊索瘤,ESBS较TCS具有明显优势。
- 对经选择的蝶骨平台和鞍结节脑膜瘤,ESBS切除率与TCS相似,视力改善率更高,近期结果中脑脊液漏发生率更低使两种入路的并发症率相近。
- 对嗅沟脑膜瘤,TCS切除率更高且并发症更少。
- 对低级别嗅神经母细胞瘤首选ESBS,但高级别肿瘤常仍需颅面入路。
- 软骨肉瘤数据少,但早期结果显示只要术者熟悉更复杂的下外侧入路,ESBS似乎在降低并发症率方面具有明显优势且切除率相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 软骨肉瘤数据少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVEEndoscopic skull base surgery (ESBS) is a relatively recent addition to the neurosurgical armamentarium. As with many new approaches, there has been significant controversy regarding its value compared with more traditional approaches to ventral skull base pathology. Although early enthusiasm for new approaches that appear less invasive is usually high, these new techniques require rigorous study to ensure that widespread implementation is in the best interest of patients.METHODSThe authors compared surgical results for ESBS with transcranial surgery (TCS) for several different pathologies over two different time periods (prior to 2012 and 2012-2017) to see how results have evolved over time. Pathologies examined were craniopharyngioma, anterior skull base meningioma, esthesioneuroblastoma, chordoma, and chondrosarcoma.RESULTSESBS offers clear advantages over TCS for most craniopharyngiomas and chordomas. For well-selected cases of planum sphenoidale and tuberculum sellae meningiomas, ESBS has similar rates of resection with higher rates of visual improvement, and more recent results with lower CSF leaks make the complication rates similar between the two approaches. TCS offers a higher rate of resection with fewer complications for olfactory groove meningiomas. ESBS is preferred for lower-grade esthesioneuroblastomas, but higher-grade tumors often still require a craniofacial approach. There are few data on chondrosarcomas, but early results show that ESBS appears to offer clear advantages for minimizing morbidity with similar rates of resection, as long as surgeons are familiar with more complex inferolateral approaches.CONCLUSIONSESBS is maturing into a well-established approach that is clearly in the patients' best interest when applied by experienced surgeons for appropriate pathology. Ongoing critical reevaluation of outcomes is essential for ensuring optimal results.
引用
- Schwartz TH, Morgenstern PF, Anand VK, et al. Lessons learned in the evolution of endoscopic skull base surgery. J Neurosurg. 2019. PMID: 30717035. doi:10.3171/2018.10.JNS182154
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。